Works matching IS 03065251 AND DT 2013 AND VI 76 AND IP 3

Results: 20

A fresh perspective on comparing the FDA and the CHMP/ EMA: approval of antineoplastic tyrosine kinase inhibitors.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 396, doi. 10.1111/bcp.12085

By:

Shah, Rashmi R.;
Roberts, Samantha A.;
Shah, Devron R.

Publication type:

Article

The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 432, doi. 10.1111/bcp.12056

By:

Kasichayanula, Sreeneeranj;
Liu, Xiaoni;
Pe Benito, Melanie;
Yao, Ming;
Pfister, Marc;
LaCreta, Frank P.;
Humphreys, William Griffith;
Boulton, David W.

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. i, doi. 10.1111/j.1365-2125.2013.04436.x
Publication type:: Article

Implications of genome-wide association studies in cancer therapeutics.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 370, doi. 10.1111/bcp.12166

By:

Patel, Jai N.;
McLeod, Howard L.;
Innocenti, Federico

Publication type:

Article

The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 467, doi. 10.1111/bcp.12159

By:

Goey, Andrew K. L.;
Meijerman, Irma;
Rosing, Hilde;
Burgers, Jacobus A.;
Mergui‐Roelvink, Marja;
Keessen, Marianne;
Marchetti, Serena;
Beijnen, Jos H.;
Schellens, Jan H. M.

Publication type:

Article

Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 338, doi. 10.1111/bcp.12203

By:

Qi, Wei‐Xiang;
Lin, Feng;
Sun, Yuan‐Jue;
Tang, Li‐Na;
Shen, Zan;
Yao, Yang

Publication type:

Article

Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 329, doi. 10.1111/bcp.12135

By:

Bonovas, Stefanos;
Nikolopoulos, Georgios;
Bagos, Pantelis

Publication type:

Article

Population pharmacokinetic-pharmacodynamic analysis for eribulin mesilate-associated neutropenia.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 412, doi. 10.1111/bcp.12143

By:

Hasselt, J. G. Coen;
Gupta, Anubha;
Hussein, Ziad;
Beijnen, Jos H.;
Schellens, Jan H. M.;
Huitema, Alwin D. R.

Publication type:

Article

Pharmacokinetic and pharmacodynamic evaluation of linagliptin in African American patients with type 2 diabetes mellitus.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 445, doi. 10.1111/bcp.12077

By:

Friedrich, Christian;
Glund, Stephan;
Lionetti, Dominick;
Kissling, C. James;
Righetti, Julian;
Patel, Sanjay;
Graefe‐Mody, Ulrike;
Retlich, Silke;
Woerle, Hans‐Juergen

Publication type:

Article

Cancer therapeutics revisited; novel drugs targeting cell signalling pathways, genome wide association studies and other trials and tribulations.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 317, doi. 10.1111/bcp.12216

By:

Lewis, Lionel D.

Publication type:

Article

Manipulating the apoptotic pathway: potential therapeutics for cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 381, doi. 10.1111/bcp.12193

By:

Bates, Darcy J. P.;
Lewis, Lionel D.

Publication type:

Article

Reduced indinavir exposure during pregnancy.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 475, doi. 10.1111/bcp.12078

By:

Cressey, Tim R.;
Best, Brookie M.;
Achalapong, Jullapong;
Stek, Alice;
Wang, Jiajia;
Chotivanich, Nantasak;
Yuthavisuthi, Prapap;
Suriyachai, Pornnapa;
Prommas, Sinart;
Shapiro, David E.;
Watts, D. Heather;
Smith, Elizabeth;
Capparelli, Edmund;
Kreitchmann, Regis;
Mirochnick, Mark

Publication type:

Article

The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 358, doi. 10.1111/bcp.12139

By:

Thompson, Ruth;
Eastman, Alan

Publication type:

Article

A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 425, doi. 10.1111/bcp.12076

By:

Boughton, Oliver;
Borgulya, Gabor;
Cecconi, Maurizio;
Fredericks, Salim;
Moreton‐Clack, Michelle;
MacPhee, Iain A. M.

Publication type:

Article

Corrigendum.

Published in:: British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 489, doi. 10.1111/bcp.12215
Publication type:: Article

Exposure to bisphosphonates and risk of colorectal cancer.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 320, doi. 10.1111/bcp.12105

By:

Ma, Jingjing;
Gao, Sheng;
Ni, Xiaojian;
Chen, Fei;
Liu, Xiaofeng;
Xie, Hui;
Yin, Hong;
Lu, Cheng

Publication type:

Article

Pioglitazone and bladder cancer: two studies, same database, two answers.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 484, doi. 10.1111/bcp.12145

By:

Vries, Frank;
Zeegers, Maurice;
Goossens, Maria E.

Publication type:

Article

Influence of plasma exchange on rituximab pharmacokinetics.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 486, doi. 10.1111/bcp.12167

By:

Azzopardi, Nicolas;
François, Maud;
Laurent, Émeline;
Paintaud, Gilles;
Birmelé, Béatrice

Publication type:

Article

Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 348, doi. 10.1111/bcp.12149

By:

Qi, Wei‐Xiang;
He, Ai‐Na;
Shen, Zan;
Yao, Yang

Publication type:

Article

Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 455, doi. 10.1111/bcp.12075

By:

Mueck, Wolfgang;
Kubitza, Dagmar;
Becka, Michael

Publication type:

Article